These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18248801)

  • 81. Tailored smart bioactive glass nanoassembly for dual antibiotic in vitro sustained release against osteomyelitis.
    Gupta N; Santhiya D; Aditya A
    J Mater Chem B; 2016 Dec; 4(47):7605-7619. PubMed ID: 32263817
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Controlled release of cargo molecules from hollow mesoporous silica nanoparticles based on acid and base dual-responsive cucurbit[7]uril pseudorotaxanes.
    Chen T; Yang N; Fu J
    Chem Commun (Camb); 2013 Jul; 49(58):6555-7. PubMed ID: 23760403
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Thermo-and pH dual-responsive mesoporous silica nanoparticles for controlled drug release.
    Chen L; Feng W; Zhou X; Yin Z; He C
    J Control Release; 2015 Sep; 213():e69-70. PubMed ID: 27005214
    [No Abstract]   [Full Text] [Related]  

  • 84. Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif.
    Park C; Oh K; Lee SC; Kim C
    Angew Chem Int Ed Engl; 2007; 46(9):1455-7. PubMed ID: 17221893
    [No Abstract]   [Full Text] [Related]  

  • 85. Letter: Superhelical structure of polypeptide aggregates.
    Masuda Y; Osumi M
    J Electron Microsc (Tokyo); 1974; 23(4):303-5. PubMed ID: 4466831
    [No Abstract]   [Full Text] [Related]  

  • 86. Controlled release of bioactive materials--28th international symposium. Tissue barriers and protein delivery.
    Unlu N; Hincal AA
    IDrugs; 2001 Sep; 4(9):1010-3. PubMed ID: 15965844
    [No Abstract]   [Full Text] [Related]  

  • 87. Controlled release of bioactive materials--28th international symposium. Carbohydrate drug carriers: cyclodextrins and chitosans.
    Sunkara G; Kompella UB
    IDrugs; 2001 Sep; 4(9):1014-6. PubMed ID: 15965845
    [No Abstract]   [Full Text] [Related]  

  • 88. Correction: Magnetic mesoporous bioactive glass for synergetic use in bone regeneration, hyperthermia treatment, and controlled drug delivery.
    Ur Rahman MS; Tahir MA; Noreen S; Yasir M; Ahmad I; Khan MB; Ali KW; Shoaib M; Bahadur A; Iqbal S
    RSC Adv; 2020 Jun; 10(41):24242. PubMed ID: 35532417
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Controlled release of bioactive materials--28th international symposium.
    Senel S; Hincal AA
    IDrugs; 2001 Sep; 4(9):1008-9. PubMed ID: 15965843
    [No Abstract]   [Full Text] [Related]  

  • 90. The pH-induced regulation of permselectivity of sugars by polymer membrane from polyvinyl-polypeptide graft copolymer.
    Chung DW; Higuchi S; Maeda M; Inoue S
    J Am Chem Soc; 1986 Sep; 108(19):5823-6. PubMed ID: 22175334
    [No Abstract]   [Full Text] [Related]  

  • 91. [Headache from excipients].
    SOLARI MA
    Dia Med; 1954 Dec; 26(88):2644. PubMed ID: 14365507
    [No Abstract]   [Full Text] [Related]  

  • 92. Antibiotic-Loaded Nano-Sized Delivery Systems: An Insight into Gentamicin and Vancomycin.
    Pisani S; Tufail S; Rosalia M; Dorati R; Genta I; Chiesa E; Conti B
    J Funct Biomater; 2024 Jul; 15(7):. PubMed ID: 39057315
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Engineering mesoporous bioactive glasses for emerging stimuli-responsive drug delivery and theranostic applications.
    Cui Y; Hong S; Jiang W; Li X; Zhou X; He X; Liu J; Lin K; Mao L
    Bioact Mater; 2024 Apr; 34():436-462. PubMed ID: 38282967
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dual drug delivery platforms for bone tissue engineering.
    V K AD; Ray S; Arora U; Mitra S; Sionkowska A; Jaiswal AK
    Front Bioeng Biotechnol; 2022; 10():969843. PubMed ID: 36172012
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effects of Chrysin-PLGA-PEG Nanoparticles on Proliferation and Gene Expression of miRNAs in Gastric Cancer Cell Line.
    Mohammadian F; Abhari A; Dariushnejad H; Nikanfar A; Pilehvar-Soltanahmadi Y; Zarghami N
    Iran J Cancer Prev; 2016 Aug; 9(4):e4190. PubMed ID: 27761206
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Three-dimensionally plotted MBG/PHBHHx composite scaffold for antitubercular drug delivery and tissue regeneration.
    Li K; Zhu M; Xu P; Xi Y; Cheng Z; Zhu Y; Ye X
    J Mater Sci Mater Med; 2015 Feb; 26(2):102. PubMed ID: 25655503
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application.
    Wu C; Chang J
    Interface Focus; 2012 Jun; 2(3):292-306. PubMed ID: 23741607
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Porous-wall hollow glass microspheres as novel potential nanocarriers for biomedical applications.
    Li S; Nguyen L; Xiong H; Wang M; Hu TC; She JX; Serkiz SM; Wicks GG; Dynan WS
    Nanomedicine; 2010 Feb; 6(1):127-36. PubMed ID: 19616128
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The pH-controlled dual-drug release from mesoporous bioactive glass/polypeptide graft copolymer nanomicelle composites.
    Xia W; Chang J; Lin J; Zhu J
    Eur J Pharm Biopharm; 2008 Jun; 69(2):546-52. PubMed ID: 18248801
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Micelle formation and drug release behavior of polypeptide graft copolymer and its mixture with polypeptide block copolymer.
    Lin J; Zhang S; Chen T; Lin S; Jin H
    Int J Pharm; 2007 May; 336(1):49-57. PubMed ID: 17134858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.